Emla Cream Versus Benzocaine on Analgesia
Upshots of 5% Emla Cream Versus 20% Benzocaine on Pre-Injection Analgesia.
Sponsor: Dow University of Health Sciences
This EARLY_PHASE1 trial investigates Effect of Drug and is currently completed. Dow University of Health Sciences leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Sep 2022 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Apr 2022 — Sep 2022 [monthly]
Completed EARLY_PHASE1
Status: Recruiting → Completed
-
Dec 2021 — Apr 2022 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Nov 2021 — Dec 2021 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Oct 2021 — Nov 2021 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Dow University of Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .